Dental Work After Breast Implants: Where the Antibiotic Prophylaxis Habit Came From and What the Evidence Says

Ask a room of women with breast implants whether they take antibiotics before the dentist and the answers will split three ways. Some were told to, by the surgeon or by a hygienist who asked about implants on the intake form. Some were told not to bother. Most were told nothing and found the question on a forum, where it circulates with the confidence of settled fact: bacteria from a cleaning enter the bloodstream, land on the implant, and cause an infection or capsular contracture, so take amoxicillin an hour before. The instruction sounds like medicine. It is closer to folklore with a prescription pad, and the story of how it got there is worth telling because it explains why so much of what patients are told about dental work after breast implants has no study behind it.

Where the prophylaxis habit came from

The instruction was copied from cardiology and orthopedics, and both fields have since withdrawn it for the great majority of their own patients. For most of the twentieth century, the American Heart Association told patients with a range of heart conditions to take antibiotics before dental work to prevent infective endocarditis, on the theory that procedure-related bacteremia seeded damaged valves. Orthopedic surgeons extended the same logic to artificial hips and knees, and plastic surgeons, who had a prosthetic device of their own, extended it once more to breast implants. The reasoning was intuitive: a foreign body, a transient shower of oral bacteria, and a plausible route between them.

Then the evidence was examined. In 2007 the AHA narrowed endocarditis prophylaxis to a short list of the highest-risk cardiac conditions and stated plainly that for everyone else the risk of antibiotic side effects exceeded any benefit; a 2021 AHA scientific statement reaffirmed that position and went further, removing clindamycin as a recommended agent because of its Clostridioides difficile risk. In 2015 the American Dental Association published a clinical practice guideline, built on a systematic review, concluding that prophylactic antibiotics are generally not recommended before dental procedures for patients with prosthetic joints. The American Academy of Orthopaedic Surgeons followed with appropriate-use criteria that reserve prophylaxis for a small subset of joint patients. Breast implants have never appeared on any of these organizations' indication lists, and the American Society of Plastic Surgeons has never issued a guideline recommending routine dental prophylaxis for implant patients. The habit survives in the plastic surgery world not because it was validated, but because it was inherited and nobody went back to check.

What the bacteremia data actually shows

Everyday chewing and toothbrushing put far more bacteria into the bloodstream over a year than the occasional dental appointment, which makes a pill before the cleaning a strange place to draw the line. The most cited measurement comes from a 2008 study in Circulation by Lockhart and colleagues, which drew serial blood cultures from patients after toothbrushing and after a single tooth extraction. Brushing produced bacteremia in roughly 23 percent of subjects and extraction in roughly 56 percent; amoxicillin given before extraction reduced the rate to about a third, but did not eliminate it. The point of the study was not that dental work is dangerous. It was that bacteremia is a routine feature of having a mouth, and that a patient with periodontal disease who brushes twice a day accumulates a cumulative exposure that dwarfs a professional cleaning twice a year.

The orthopedic literature then asked the question that matters: does any of this bacteremia actually infect implants, and does prophylaxis prevent it? A 2010 case-control study in Clinical Infectious Diseases by Berbari and colleagues at the Mayo Clinic compared 339 patients with infected hip or knee prostheses against matched controls with uninfected ones. Dental procedures were not associated with prosthetic joint infection, and antibiotic prophylaxis before those procedures did not reduce the risk. That finding, in a device with a synovial space that is far more hospitable to bacteria than a breast implant capsule, is the central reason orthopedics changed its guidance. There is no equivalent study for breast implants because late hematogenous infection of a breast implant is rare enough that a case-control design would struggle to enroll cases. Rarity is itself the finding. Late periprosthetic breast infections are documented in case reports, some of them following a dental procedure and some following infections elsewhere in the body, and a case report is a record of something that happened once, not a measure of how often it happens.

"

Cardiology and orthopedics both examined the dental prophylaxis habit and withdrew it for most of their patients. Plastic surgery inherited the habit, never ran the study, and in many practices never withdrew it.

"

Why a breast implant is not a knee, and why that cuts both ways

The tissue around a breast implant is a poor place for a bloodborne bacterium to land, which argues against routine prophylaxis, but the implant surface does host biofilm, which is why the question is not entirely silly. An artificial joint sits in a synovial cavity with fluid, motion, and metal-on-polymer wear debris, an environment in which circulating bacteria can settle and multiply. A breast implant, once healed, is enclosed in a fibrous capsule with minimal fluid, and the capsule matures into a relatively avascular scar layer within months. Bloodborne seeding of that space is possible but improbable, and the clinical record reflects that: the overwhelming majority of breast implant infections occur in the first weeks after surgery, from contamination at the time of placement or from a wound or drain site, not from the bloodstream a year later.

The complication that worries surgeons more than frank infection is capsular contracture, and here the biofilm hypothesis enters the conversation. Work by Pajkos and colleagues in Plastic and Reconstructive Surgery in 2003 cultured bacteria from a majority of contracted capsules and a minority of soft ones, and subsequent research by Deva and others established that a subclinical bacterial biofilm on the implant surface can drive chronic inflammation and capsule thickening. That evidence is the basis for the fourteen-point plan of intra-operative measures, antibiotic irrigation, and no-touch insertion that most surgeons now follow. It is also the evidence that some surgeons extrapolate to dental prophylaxis: if biofilm causes contracture, and bacteremia could add bacteria to the implant, then prevent the bacteremia. The extrapolation fails at the second step. The biofilm research points to contamination at the moment of insertion, when the implant is bare and the pocket is open, not to seeding of a sealed capsule years later. A patient who believes her cleaning caused her contracture is almost always describing a coincidence in timing with a process that began on the operating table.

What the pill costs

Antibiotic prophylaxis is not harmless, and the cost side of the ledger is what finally changed the guidelines in the other fields. A single dose of amoxicillin carries a small but real risk of anaphylaxis, and repeated doses over a lifetime of dental visits multiply the exposures. Clindamycin, the standard substitute for penicillin-allergic patients for decades, was dropped from the AHA's 2021 recommendations because of its association with C. difficile colitis, a complication that hospitalizes patients and occasionally kills them. Every course also contributes to antimicrobial resistance, which is an abstract concern for an individual and a concrete one for the population of surgical patients who will need those drugs to work. The ADA's 2015 guideline was explicit that when the expected benefit is unmeasurable and the harm is measurable, the default is not to prescribe.

There is also a subtler cost, which is what the prescription teaches the patient. A woman told to premedicate for every cleaning learns that her implants are fragile, that ordinary life threatens them, and that the surgeon's office is the place to call for permission before routine care. Some patients respond by avoiding the dentist, which is a genuine harm: untreated periodontal disease produces exactly the chronic, high-volume bacteremia the pill was supposed to prevent. The long-term care of breast implants involves imaging, awareness of symptoms, and an eventual decision about replacement or removal. It does not involve an amoxicillin bottle in the bathroom cabinet.

When the question deserves a real answer

There is a narrow set of circumstances in which a surgeon's individualized judgment about dental timing or prophylaxis is reasonable, and they are defined by the patient and the calendar, not by the presence of an implant. The first is recency. Most surgeons ask patients to postpone elective dental work, especially extractions and deep cleanings, for the first several weeks after augmentation or exchange, on the theory that the pocket is still healing, the capsule is immature, and the implant surface has not yet been walled off. There is no trial behind a six-week rule any more than there is behind a four-week one, but the biological reasoning is sounder here than anywhere else in this debate, and a patient can wait without cost. Emergency dental treatment should never be delayed for an implant; an abscess is a far more reliable source of bacteremia than the procedure that drains it.

The second is host risk. Patients on immunosuppressive medications, with poorly controlled diabetes, or with a history of a prior implant infection or hematogenous infection of any device sit outside the population the joint studies enrolled, and the AAOS criteria carve out similar groups. For those patients, a surgeon and a dentist talking to each other is the right process, and the answer may still be no. The third is the special case of tissue expanders and recently placed reconstructive devices, where infection rates are higher than in cosmetic augmentation and some reconstructive surgeons remain more cautious. None of these exceptions describes the typical patient, a healthy woman two years past an uncomplicated augmentation, who is the person most often carrying the prescription. The related question of whether dental work stirs up filler nodules is a separate one, with its own literature on inflammatory triggers, and should not be confused with the implant question.

The honest summary

Routine antibiotic prophylaxis before dental work for patients with breast implants is a habit inherited from cardiology and orthopedics, both of which examined the evidence and withdrew the recommendation for the large majority of their patients. The bacteremia from a dental cleaning is real but is dwarfed by the cumulative bacteremia of chewing and brushing, and the strongest available case-control data, in joint prostheses that are far more susceptible than a breast capsule, found no link between dental procedures and device infection and no protective effect from prophylaxis. Late hematogenous breast implant infection exists in case reports and nowhere else. Capsular contracture is driven by biofilm seeded at surgery, not by the dentist. The antibiotics themselves carry measurable risks of allergy, C. difficile, and resistance, and the instruction teaches patients to treat their implants as fragile and their dentist as a threat, which pushes some of them away from the dental care that actually reduces bacteremia. The reasonable exceptions are early recovery, immunocompromise, prior implant infection, and recently placed reconstructive devices. For everyone else, go to the dentist, brush your teeth, and ask any practice that hands you a standing prescription to name the guideline it is following.